WeedWeek, 12/16/17: Peter Thiel’s Magic Mushroom Play to Begin Clinical Trials

Posted by | December 17, 2017 | Cannabis News, Weed Week News by Alex Halperin


WeedWeek, 12/16/17: Peter Thiel’s Magic Mushroom Play to Begin Clinical Trials

DID YOU KNOW? You can list your conferences, festivals and parties for FREE on the site.
Check out those upcoming events here.
Would you appreciate a WeedWeek regional supplement with more news from California and/or Canada? Or more news about the opioid crisis? Sign up at the appropriate link.
If you consider WeedWeek a valuable resource, consider supporting us with a monthly contribution on Patreon.
Swag and discounts start at $2 a month.
For $25 a month you get five (5!) WeedWeek stickers, discounts to all future WeedWeek events, a postcard from Los Angeles, cannabis capital of the world and you get to join a monthly Google hangout with me and other WeedWeek supporters to discuss the latest news…
Brandbuilding opportunities to appear in the newsletter with your links and social media handles start at only $50 a month.
WeedWeek has introduced a new feature called WeedWeek Forum, the cannabis world’s Op-Ed page. Many of you are are eager to share your thoughts and expertise. Here’s your chance to publish on the WeedWeek site.
WeedWeek publishes 400-600 word essays, arguments, observations and fact-based criticisms by outside contributors. We do not accept payment for publishing work.
This week, Centuria CEO Michael Brubeck warns cannabis investors: Get ready to lose everything.
Want to contribute? Check out the writer’s guidelines here.
WeedWeek’s Holiday Gift Guide is up featuring special offers on some great gear.
Contact Adrienne Nascimento to add an offer for your product.
Here’s the news.
After Attorney General Jeff Sessions met with legalization opponents, Tom Angell asked Twitter if anyone could expand a photo of the agenda. It revealed “a concerted pitch during the meeting to convince Sessions to launch a federal crackdown on states that have ended cannabis prohibition.”
In an email, I asked attendee and anti-legalization activist Kevin Sabet if he could make a political case for a crackdown. He didn’t respond.
Reminder: The Rohrabacher-Blumenauer Amendment, which blocks Sessions’ Justice Department from prosecuting state-legal MED businesses, expires on Friday.
Doug Jones (D), the former prosecutor who won Sessions’ former Senate seat in Alabama, has far more liberal views on criminal justice reform.
California issued its first batch of cannabis business licenses. Fast Company asks if the market is ready after a year of wildfires.
The state created a digital tool to help grey market businesses go legit. Cheech Marin promoted it in a PSA.
San Francisco Mayor Ed Lee died unexpectedly. As the city’s first Asian-American mayor, he faced criticism from elderly Chinese for his support for cannabis businesses. Acting mayor London Breed also supports legalization.
App looks at the path to legal REC in New JerseyEntrepreneurs are excited about weed in the Garden State.
Vermont could legalize REC within weeks. Hawaii voters oppose legal REC.
Cook County (Chicago) may give voters a chance to legalize REC. Hartford City Council supports REC legalization in Connecticut.
For cannabis, Leafly says the end of net neutrality, “could stifle advocacy efforts, hamper small businesses, and prevent medical patients from accessing vital information.”
City regulated consumption lounges may be coming to Vegas. Massachusetts approved a social use policy. Denver received its first application for social use from a business called The Coffee Joint.
Massachusetts is considering equity provisions to support minority cannabis entrepreneurs.
Maryland released data on diversity in the state’s industry.
An Arizona state senator wants to ban MED billboards. MED patient enrollment is way up in New Mexico.
Ohio defended its license award process against critics. A scorer had ties to a company awarded one of the 12 coveted large grow licenses.
More than 70% of Georgia Republicans support legal MED.
Canadian senators may want to grill Prime Minister Justin Trudeau about legalization. And some conservatives in the body say REC legalization could be delayed past the anticipated July 1 launch. Ontario’s REC law takes effect July 1, 2018.
An opinion piece in iPolitics says it’s not a problem that Canadian legalization violates several international treaties.
Canadian provinces appear settled on a 75-25 revenue split with the federal government on pot taxes after rejecting a proposed 50-50 split. Coming soon, local governments politely ask for their share.
Provincial laws banning home grows could be overturned in court.
REC legalization appears to be working in Uruguay.
Compass Pathways, a U.K. company investigating psilocybin as a treatment for depression, plans to begin clinical trials next year. Silicon Valley eminence Peter Thiel, whose Founders Fund previously invested in cannabis firm Privateer Holdings, is an investor.
As it tries to hold off a hostile takeover by Aurora, Canadian MED producer CanniMed says Aurora may have violated securities law as part of its bid.
Leafly’s Peter Hecht dives into the leadership struggle at troubled social app MassRoots. Alan Brochstein offers “seven warning signs investors should have heeded.”
Baker, a software platform for dispensaries to retain customers, raised $8M in a round led by Poseidon Asset Management. The company says revenue is up 600% since January.
Canna Law Blog discusses what blockchain financial technology could mean for cannabis.
Bloomberg looks at the racketeering (RICO) lawsuits threatening cannabis businesses. MJBizDaily has more on this “existential threat” to the industry.
The Fort Worth Star-Telegram profiles two Texan executives at Colorado-based Organa Brands (O.Pen Vape.)
After Eugene Antifa activists disclosed ties between Oregon lab OG Analytical and white supremacists, consumers have directed anger against other businesses with OG in their name.
Debit app CanPay will offer cashless payments at some Maryland dispensaries. CanPay CEO Dustin Eide discusses how the service helped Hawaii’s MED program to go cashless.
A company dropped plans for a $20M grow in Michigan.
Canadian cannabis companies raised more than $1.5 billion in 2017. Even if you think it’s a bubble, It’s difficult to short sell Canadian pot stocks.
Lovell’s Drugs became the third Canadian pharmacy chain to sign a deal to sell MED.
An opinion piece at USNews asks how NAFTA will affect marijuana markets.
Quartzy looks at upscale smoking accessories and says, “For some cannabis-curious consumers, good design just might be the ultimate gateway drug.”
Weed and wine tours are increasingly a thing. California winery Rebel Coast released an alcohol-removed, cannabis-infused sauvignon blanc.
Sponsored Content
Introducing incredible Wellness, a line of cannabinoid health products including THC & CBD tinctures, a distillate vaporizer, 500mg THC bath salts and high milligram cannabinoid suppositories. In the wake of a study released this week in the Journal of the American Medical Association stating that a third of CBD products are mislabeled- incredible Wellness is committed to triple testing every single product and mandates the use of the highest-quality ingredients.
“Cannabis has become paramount in my healing process. After an NFL career full of injury to both my brain and body, I use CBD daily as a tool to combat inflammation. Pain can tend to get in the way of everyday activity. CBD can help take the edge off as you get through your day and address your ailments!” – Eugene Monroe, retired NFL player.
A study found THC may reduce the cognitive decline common in HIV patients. Another study found CBD can reduce symptoms in patients with psychosis.
A study found cannabis and vaping are more popular than cigarettes among teenagers. The study found teen cannabis use is largely holding steady while use of other illegal drugs has held steady or declined.
The World Health Organization said CBD doesn’t warrant international scheduling.
Pediatric healthcare workers have

177 total views, 1 today

Tags: ,

One Response to “WeedWeek, 12/16/17: Peter Thiel’s Magic Mushroom Play to Begin Clinical Trials”

Sorry, the comment form is closed at this time.